Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03823209 · ClinicalTrials.gov registry record · NA
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
A NA study of Human Immunodeficiency Virus, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT03823209 is a NA study of Human Immunodeficiency Virus that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 500 participants, above the 171-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (192% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT03823209, a NA study of Human Immunodeficiency Virus, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the use of a social-network approach to encourage African-American men who have sex with men (AAMSM) to adopt pre-exposure prophylaxis (PrEP) to prevent HIV infection. Thirty-six networks of AAMSM will be recruited in Milwaukee, WI, and Cleveland, OH. Half of these networks will have their leaders trained to endorse PrEP to their social network members, and the other half will be given brief HIV prevention counseling.
Conditions Studied
Interventions
- BEHAVIORAL Social Network
- BEHAVIORAL Brief HIV Prevention Counseling
Study Locations (2)
Ohio
- AIDS TaskForce of Greater Cleveland - Cleveland
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-01-24 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03823209
The ClinicalTrials.gov registry entry for NCT03823209 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 171-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (192% higher). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 2 interventions - of which Social Network is the first listed.
NCT03823209 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03823209 about?
NCT03823209 is a clinical study titled "Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities". This study evaluates the use of a social-network approach to encourage African-American men who have sex with men (AAMSM) to adopt pre-exposure prophylaxis (PrEP) to prevent HIV infection. Thirty-six networks of AAMSM will be recruited in Milwaukee, WI, and Cleveland, OH. Half of these networks will...
What is the current status of trial NCT03823209?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2019-01-24. Estimated completion is 2025-12-01.
What conditions does trial NCT03823209 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT03823209?
The interventions under investigation include: Social Network (BEHAVIORAL), Brief HIV Prevention Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03823209?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03823209 being conducted?
This trial has 2 study locations across Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
COMPLETED · NA
-
CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.